Technical Analysis for QLGN - Qualigen Therapeutics, Inc.

Grade Last Price % Change Price Change
F 0.17 -3.60% -0.01
QLGN closed down 3.6 percent on Monday, July 1, 2024, on 39 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion -3.60%
MACD Bullish Signal Line Cross Bullish -6.74%
Wide Bands Range Expansion -6.74%
New 52 Week Closing Low Bearish -0.60%
NR7 Range Contraction -0.60%
Wide Bands Range Expansion -0.60%

   Recent Intraday Alerts

Alert Time
Down 5% about 4 hours ago
Down 3% about 4 hours ago
Up 3% about 4 hours ago
Down 2 % about 4 hours ago
Down 1% about 4 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Qualigen is a biotechnology company focused on developing novel products for the treatment and testing of cancer and infectious diseases. Its current commercial product is the FastPack rapid diagnostic testing system. This "Laboratory in a Pouch" is installed in physician offices, clinics and small hospitals around the world, and quickly detects diseases and medical conditions at the point-of-care. Since its inception almost 20 years ago, FastPack has generated more than $100 million in commercial sales. Qualigen's worldwide distributor for FastPack is Sekisui Diagnostics, a subsidiary of a multibillion-dollar Japanese chemical and technology company. Sekisui owns approximately 15.8% of Qualigen's outstanding common shares.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Chemical Disease Infectious Diseases Clinic Medical Test Novel Products

Is QLGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.25
52 Week Low 0.1449
Average Volume 1,511,769
200-Day Moving Average 0.53
50-Day Moving Average 0.26
20-Day Moving Average 0.20
10-Day Moving Average 0.18
Average True Range 0.03
RSI (14) 35.48
ADX 10.79
+DI 21.51
-DI 20.76
Chandelier Exit (Long, 3 ATRs) 0.24
Chandelier Exit (Short, 3 ATRs) 0.24
Upper Bollinger Bands 0.26
Lower Bollinger Band 0.14
Percent B (%b) 0.22
BandWidth 60.58
MACD Line -0.03
MACD Signal Line -0.03
MACD Histogram 0.0003
Fundamentals Value
Market Cap 860.57 Thousand
Num Shares 5.18 Million
EPS -4.07
Price-to-Earnings (P/E) Ratio -0.04
Price-to-Sales 0.56
Price-to-Book 0.35
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.19
Resistance 3 (R3) 0.19 0.19 0.19
Resistance 2 (R2) 0.19 0.18 0.19 0.19
Resistance 1 (R1) 0.18 0.18 0.17 0.17 0.19
Pivot Point 0.17 0.17 0.17 0.17 0.17
Support 1 (S1) 0.16 0.16 0.15 0.16 0.15
Support 2 (S2) 0.15 0.16 0.15 0.15
Support 3 (S3) 0.14 0.15 0.14
Support 4 (S4) 0.14